Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165775 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 17
- Enrollment target
NCT01165775: Completed study, sponsored by Stanford University.
NCT01165775 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01165775 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.
Interventions
- DEVICE Dexcom Seven Plus Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01165775
The ClinicalTrials.gov registry entry for NCT01165775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Seven Plus Continuous Glucose Monitoring System is the first listed.
NCT01165775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01165775 about?
NCT01165775 is a clinical study titled "Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy". We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent matern...
What is the current status of trial NCT01165775?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2010-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01165775?
The interventions under investigation include: Dexcom Seven Plus Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01165775?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.